#United States #Novo Nordisk #Plainsboro #Ozempic #Type 2 Diabetes

Novo Nordisk Launches 'My Ozempic® Era' Campaign

Novo Nordisk has officially unveiled its latest initiative, the 'My Ozempic® Era,' aimed at raising awareness around type 2 diabetes through real-life narratives. This national campaign features compelling stories from individuals who have successfully managed their diabetes using Ozempic® (semaglutide) alongside dietary and exercise modifications.

The campaign shines a spotlight on three notable personalities: award-winning musician Michael Trotter Jr., acclaimed chef Franklin Becker, and salon owner Maria. Each ambassador shares their personal experiences on how they navigate life with type 2 diabetes, a condition impacting over 38 million adults in the U.S. They offer a glimpse into their unique health journeys and the role Ozempic® has played in improving their lives.

Michael recalls witnessing family members struggle with diabetes, which motivated him to take control of his health following his own diagnosis. "Upon learning my condition, I recognized the importance of managing it proactively, especially as my wife and I pursued our music together," he states. With the integration of Ozempic® into his routine, Michael has successfully lowered his A1C levels, allowing him to thrive both personally and professionally.

Chef Franklin Becker echoes similar sentiments, recounting the adjustments he made in his lifestyle to address his diabetes. He emphasizes that proper dietary choices combined with Ozempic® have enabled him to balance his health with his culinary career, showcasing that diabetes management does not preclude one from pursuing their passions.

Maria, an entrepreneur, highlights her journey of accountability in managing her diabetes, emphasizing the challenge and importance of staying committed to a treatment plan. Together, they aspire to motivate others to embrace their health journeys and explore treatment options that can positively impact their lives.

Tivonnia (T.J.) Harvey, Head of U.S. Diabetes Therapeutic Area at Novo Nordisk, underscores the campaign's goal: to inspire individuals living with type 2 diabetes to engage with their treatment options proactively. Encouraging stories like those shared by Michael, Franklin, and Maria illustrate the potential of combining lifestyle changes with medically supervised treatments.

With Ozempic® being a prescribed injectable medicine, Novo Nordisk seeks to provide clarity about its efficacy and safety, particularly amidst the growing discussion around alternative medications. Since its FDA approval in 2017, Ozempic® has gained recognition for its ability to improve blood sugar levels and lower the risk of serious cardiovascular issues, making it a valuable option for adults managing this chronic condition.

Both the participants and Novo Nordisk aim to address the overwhelming nature of a diabetes diagnosis, urging patients—newly diagnosed or long-term—to consider a treatment plan that includes healthy lifestyle changes, diet, and exercise as complementary elements alongside Ozempic®.

To explore more about the 'My Ozempic® Era' campaign and gain insights into diabetes management, visit MyOzempicEra.com. The stories shared are not only motivating but serve as a reminder of the proactive steps individuals can take in their health journeys. As Novo Nordisk continues its commitment to diabetes care, it emphasizes the importance of community, education, and support, aiming for a future where managing diabetes is met with empowerment and positivity.

Novo Nordisk remains a leader in innovative diabetes solutions, focusing on creating a supportive environment for those navigating this condition. With continuous research and development, they strive to foster long-term health improvements for diabetes patients worldwide.